4/A//SEC Filing
Hemrajani Rekha 4/A
Accession 0001415889-25-007506
CIK 0001709941other
Filed
Mar 9, 8:00 PM ET
Accepted
Mar 10, 4:11 PM ET
Size
5.1 KB
Accession
0001415889-25-007506
Insider Transaction Report
Form 4/AAmended
Hemrajani Rekha
Director
Transactions
- Purchase
Common Stock
2024-09-27$18.00/sh+3,000$54,000→ 3,000 total
Footnotes (1)
- [F1]The reported securities were purchased through a directed share program in connection with the Issuer's initial public offering.
Documents
Issuer
BioAge Labs, Inc.
CIK 0001709941
Entity typeother
Related Parties
1- filerCIK 0001771213
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 9, 8:00 PM ET
- Accepted
- Mar 10, 4:11 PM ET
- Size
- 5.1 KB